Harbor

Status: Completed

ClinicalTrials.gov Identifier: NCT00891735

Harbor: Ranibizumab Injections administered on monthly or as needed basis in patients with wet AMD.

Condition: Age-Related Macular Degeneration

Study Type: Interventional

Duration: 3 years

Eligibility: 

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.